When Benign Tumors Mimic Malignancies: A Case of Lymphangiomatosis Masquerading as Metastatic Disease.

Rare cancers and therapy Pub Date : 2013-01-01 Epub Date: 2013-09-28 DOI:10.1007/s40487-013-0001-9
Kristen R Spencer, Markku M Miettinen, Robert G Maki, Janice M Mehnert
{"title":"When Benign Tumors Mimic Malignancies: A Case of Lymphangiomatosis Masquerading as Metastatic Disease.","authors":"Kristen R Spencer,&nbsp;Markku M Miettinen,&nbsp;Robert G Maki,&nbsp;Janice M Mehnert","doi":"10.1007/s40487-013-0001-9","DOIUrl":null,"url":null,"abstract":"<p><p>Lymphangiomatosis, a rare disorder of the lymphatic system characterized by the abnormal proliferation of lymphatic vessels, is a typically benign disorder that at times can exhibit invasive or malignant behavior. While generally considered a diagnosis of childhood, in adults the majority of cases are asymptomatic and found incidentally. Rarely, lymphatic overgrowth can occur, causing growth of lesions on imaging mimicking a metastatic process and occasionally, resulting in substantial morbidity and mortality. Here, we present such a case of lymphangiomatosis with multi-organ system involvement in liver, bone, and spleen. In addition to details of the clinical presentation and the pathologic review which led to the diagnosis, we describe our use of the tyrosine kinase inhibitor pazopanib, which may cause stabilization of lymphangiomatosis through blockade of vascular endothelial growth factor (VEGF) signaling, for systemic treatment in this unusual case.</p>","PeriodicalId":91604,"journal":{"name":"Rare cancers and therapy","volume":"1 ","pages":"21-27"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40487-013-0001-9","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rare cancers and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40487-013-0001-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2013/9/28 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Lymphangiomatosis, a rare disorder of the lymphatic system characterized by the abnormal proliferation of lymphatic vessels, is a typically benign disorder that at times can exhibit invasive or malignant behavior. While generally considered a diagnosis of childhood, in adults the majority of cases are asymptomatic and found incidentally. Rarely, lymphatic overgrowth can occur, causing growth of lesions on imaging mimicking a metastatic process and occasionally, resulting in substantial morbidity and mortality. Here, we present such a case of lymphangiomatosis with multi-organ system involvement in liver, bone, and spleen. In addition to details of the clinical presentation and the pathologic review which led to the diagnosis, we describe our use of the tyrosine kinase inhibitor pazopanib, which may cause stabilization of lymphangiomatosis through blockade of vascular endothelial growth factor (VEGF) signaling, for systemic treatment in this unusual case.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
当良性肿瘤模仿恶性肿瘤:一例淋巴管瘤病伪装成转移性疾病。
淋巴管瘤病是一种罕见的淋巴系统疾病,以淋巴管异常增生为特征,是一种典型的良性疾病,有时可表现出侵袭性或恶性行为。虽然通常被认为是儿童期的诊断,但在成人中,大多数病例是无症状的,是偶然发现的。很少,淋巴过度生长可以发生,引起病变的生长在影像学上模仿转移过程,偶尔,导致大量的发病率和死亡率。在此,我们报告一例多器官系统累及肝脏、骨骼和脾脏的淋巴管瘤病。除了详细的临床表现和导致诊断的病理检查,我们描述了我们使用酪氨酸激酶抑制剂pazopanib,它可能通过阻断血管内皮生长因子(VEGF)信号导致淋巴管瘤病的稳定,在这个不寻常的病例中进行全身治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Acute Myeloid Leukemia in the Elderly Patient: New Strategies. An Overview on the Sequential Treatment of Pancreatic Neuroendocrine Tumors (pNETs). Bosutinib for Chronic Myeloid Leukemia. Evolving Paradigms in the Management of Multiple Myeloma: Novel Agents and Targeted Therapies. Treatment of Adult Soft Tissue Sarcomas: An Overview.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1